HOME >> BIOLOGY >> NEWS
Abnormal chromosomes forecast leukemia relapse

COLUMBUS, Ohio Patients with acute myeloid leukemia (AML) who enter remission with abnormal chromosomes in bone marrow cells are twice as vulnerable to recurrence of their disease as are AML patients with normal bone marrow cells at remission, according to a new study.

The findings by researchers at The Ohio State University Comprehensive Cancer Center Arthur G. James Cancer Hospital and Richard J. Solove Research Institute call for routine testing for chromosomal abnormalities in AML patients at diagnosis and again when patients enter remission.

If verified, the findings mean that AML patients showing chromosomal abnormalities early during remission should be considered for more intensive treatment, such as a bone marrow transplant, in an attempt to prevent a return of the disease. Patients with normal-looking chromosomes can receive standard therapy.

The findings are published in the June 15 issue of the Journal of Clinical Oncology.

"For the first time, we have shown in a relatively large group of patients that someone with AML who has abnormal chromosomes early during remission will relapse, even if blood counts and other parameters are favorable," says first author Guido Marcucci, associate professor of internal medicine and a hematologist/oncologist with OSU's James Cancer Hospital.

Since 1990, physicians have said that AML patients were in complete remission following treatment if their blood count was normal, and their bone marrow contained fewer than 5 percent of immature cells known as blasts.

By that definition, 60 percent to 70 percent of AML patients achieve complete remission, but only 30 percent to 40 percent of those patients remain in remission long enough to be considered completely cured of their disease.

"Achieving complete remission is an important step for a successful treatment," Marcucci says, "but it does not predict who will do well in the long run and who will relapse. We need
'"/>

Contact: Darrell E. Ward
Ward-15@medctr.osu.edu
614-293-3737
Ohio State University
16-Jun-2004


Page: 1 2

Related biology news :

1. Abnormally high number of Lou Gehrigs disease cases identified among Gulf War veterans
2. Abnormal plant shows scientists path to plant, animal development
3. Abnormal immune response may play major role in glaucoma, study says
4. Abnormalities in cellular anchoring protein cause fatal heart syndrome
5. Abnormal chemical bonds cause bleeding disorder
6. Abnormalities in stress hormone response among alcoholics
7. Researchers Find Protein Abnormality Associated With Alzheimers Disease
8. Scientists Show That Normal-looking Cells In Cervical Cancer May Be Abnormal
9. Multi-Center Study Provides Guidelines For Genetic Testing In Women With Breast Cancer: BRCA Abnormalities Multiply Risk Of Ovarian Cancer
10. UB Fertility Researchers Find They Can Predict Pregnancy By Assessing Two Sperm Abnormalities
11. COGA Suggests Genetic Loci For P3 Brain Wave Abnormality

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... BioInformatics Inc., ... as Chief Commercial Officer of the life science research and advisory firm. As ... and alignment of all market research and media revenue operations in the company. ...
(Date:2/19/2019)... N.J. (PRWEB) , ... February ... ... the leading global provider of advanced delivery technologies and development solutions for ... The Procter & Gamble Company’s (P&G) highest external business partner recognition, the ...
(Date:2/19/2019)... ... ... Idea, Emma came home from her first day of elementary school with a long list ... out there to make her homework a little more fun. Unable to find anything suitable, ... is simple enough: help children learn the vocabulary they see in school — not just ...
Breaking Biology News(10 mins):
(Date:2/19/2019)... , ... February 19, 2019 , ... VetStem Biopharma ... and manufacturing experience. In October 2018, VetStem authorized the formation of Personalized Stem ... PSC its stem cell patents, data, and FDA filings to launch into human stem ...
(Date:2/16/2019)... ... , ... DaVinci is a comprehensive data integration platform with ... for users to bring their own data and tools to the platform via ... analytics on near-real-time data to gain timely insights on manufacturing processes. , By ...
(Date:2/14/2019)... ... February 14, 2019 , ... Leak ... systems for the pharmaceutical, biotechnology and food industries, formally announced today the appointment ... Mulhall has been named Chief Executive Officer and will oversee all aspects ...
(Date:2/12/2019)... ... February 12, 2019 , ... Innovaderm Research, Inc., ... to extend their use of Medrio, the leading provider of eClinical technology for ... been a regular Medrio customer for over nine years, primarily using the software ...
Breaking Biology Technology:
Cached News: